Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMincon Grp Regulatory News (MCON)

Share Price Information for Mincon Grp (MCON)

Share Price is delayed by 15 minutes
Get Live Data
58.00    0.00 (0.00%)
Bid:
56.00
Ask:
60.00
Spread: 4.00 (7.143%)
Market Cap: £123.23m
MCON Live PriceLast checked at - London Stock Exchange

Intraday Mincon Grp Share Chart

Board Changes

6 Dec 2023 07:00

RNS Number : 7839V
Mincon Group Plc
06 December 2023
 

Mincon Group plc

("Mincon" or the "Group")

 

Board Changes

 

Mincon Group plc (Euronext:MIO; AIM:MCON), the Irish engineering group specialising in the design, manufacture, sale and servicing of rock drilling tools and associated consumable products, is pleased to announce the appointment of Ms. Orla O'Gorman as an independent, non-executive director of the Company, with immediate effect. The Group also announces the impending retirement of Mr. John Doris on the 1st of February 2024.

 

Appointment of Director

Orla O'Gorman has extensive corporate finance and capital markets experience in a variety of roles. She held senior management positions at PwC, ABN Amro and Eurologic Systems before founding OR Associates which provided niche transaction management and corporate finance services to public and private companies.

 

Orla joined the Irish Stock Exchange plc ("ISE") in September 2014 as Head of Equity, with responsibility for the Irish equity market. When Euronext acquired the ISE in March 2018 Orla became Head of Listing Ireland and subsequently the UK for the Group.

 

Orla O'Gorman is currently a non-executive director with Cairn Homes plc, Cubic Telecom, Bon Secours Health System and Elite SpA; she is also a member of the Elkstone Ventures Advisory Board. She is a Member of Chartered Accountants Ireland ("CAI") Sustainability Expert Working Group and the Ethics & Governance Committee. Orla is a qualified accountant, holds a Bachelor of Commerce from University College Dublin and a Master of Accounting from UCD Smurfit School.

 

Hugh McCullough, Chairman of Mincon, commented: "I am delighted to welcome Orla to the board of Mincon as we continue to develop and diversify our drilling tool business. She brings extensive practical, commercial experience to the Board and her focus on sustainable development is very much in keeping with the Group's existing manufacturing ethos. I know she will make an important contribution to the Group's global business."

 

 

 

Retirement of Director

The Group also announces the impending retirement of our Senior Independent Non Executive Director, John Doris, who will step down from the Board on 1 February 2024. John has had extensive experience with the Group since 2014 when he acted as Interim CFO and then subsequently as Company Secretary until his appointment as Senior Independent Non Executive Director in February 2017.

 

Existing Director, Paul Lynch, will assume the role of Senior Independent Non Executive Director upon John's retirement.

 

Hugh McCullough, Chairman of Mincon, commented: "John has been a consistently active and committed director who has given important service to the Group over the many years of his association. He has always put the Group's interest first and has been an extremely diligent and positive contributor to Board affairs. We will miss John's presence; we thank him for his contribution to Mincon and we wish him continued success in his other corporate activities."

 

Additional Information:

 

The following information regarding the appointment of Orla O'Gorman, aged 51, is disclosed under Schedule 2(g) of the AIM Rules for Companies:

 

Current Directorships / Partnerships

Past Directorships / Partnerships

Bon Secours Health System CLG

HealthBeacon plc

Cairn Homes plc

Cubic Telecom Limited

Elite SpA

Powertherm Solutions Limited

 

Ms. O'Gorman does not hold any Ordinary Shares of the Company.

 

Orla O'Gorman served as a non-executive Director of HealthBeacon plc between 26 April 2022 and 1 February 2023. On 27 October 2023, the Irish High Court appointed an interim examiner to HealthBeacon.

 

The Company confirms that there is no other information that is required to be disclosed under Schedule 2(g) of the AIM Rules for Companies.

 

 

Ends

6th December 2023

 

For further information please contact

 

Mincon Group plc

Joe Purcell - Chief Executive Officer Tel: +353 (61) 361 099

Mark McNamara - Chief Financial Officer

 

Davy Corporate Finance (Nominated Adviser, Euronext Growth Listing Sponsor and Joint Broker)

Anthony Farrell Tel: +353 (1) 679 6363

Daragh O' Reilly

 

Shore Capital (Joint Broker)

Malachy McEntyre Tel: +44 (0) 20 7408 4090

Mark Percy

Daniel Bush

 

 

Forward looking statements

Any forward-looking statements made in this document represent the Board's best judgment as to what may occur in the future. However, the Group's actual results for the current and future financial periods and corporate developments will depend on a number of economic, competitive and other factors, some of which will be outside the control of the Group. Such factors could cause the Group's actual results for future periods to differ materially from those expressed in any forward-looking statements included in this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPASEENDFFA
Date   Source Headline
2nd Jun 20267:00 amRNSChange in Nomad
29th May 202610:42 amRNSHolding(s) in Company
29th May 202610:16 amRNSHolding(s) in Company
29th Apr 20263:13 pmRNSResult of AGM
29th Apr 20267:00 amRNSInterim Trading Update
26th Mar 20267:00 amRNSAnnual Report and Notice of AGM
20th Mar 20265:00 pmRNSDirector/PDMR Shareholding
10th Mar 20261:36 pmRNSHolding(s) in Company
10th Mar 20267:00 amRNSFinal Results
10th Mar 20267:00 amRNSFinal Results
5th Mar 202611:30 amRNSHolding(s) in Company
29th Jan 20266:12 pmRNSHolding(s) in Company
19th Jan 20262:52 pmRNSHolding(s) in Company
23rd Oct 20257:00 amRNSQ3 2025 Trading Update
26th Sep 20259:42 amRNSDirectorate Change
5th Aug 20257:00 amRNSHalf-year Report
19th May 20257:00 amRNSBoard Changes
1st May 20254:30 pmRNSResult of AGM
1st May 20257:00 amRNSInterim Trading Update
26th Mar 202512:00 pmRNSAnnual Report and Notice of AGM
10th Mar 20257:00 amRNSFinal Results
30th Dec 20244:00 pmRNSHolding(s) in Company
29th Oct 20247:00 amRNSDividend Notice
25th Oct 20247:00 amRNSInterim Trading Update
6th Aug 20247:00 amRNSHalf Yearly Report
7th May 20247:00 amRNSInterim Trading Update
2nd May 20245:00 pmRNSResult of AGM
27th Mar 20247:00 amRNSAnnual Report and Notice of AGM
15th Mar 20247:00 amRNSDirector/PDMR Shareholding
11th Mar 20247:00 amRNSFinal Results
6th Feb 20247:00 amRNSFull Year Trading Update and Notice of Results
6th Dec 20237:00 amRNSBoard Changes
1st Dec 20237:00 amRNSDirector/PDMR Shareholding
9th Oct 20237:00 amRNSInterim Trading Update
8th Aug 20237:00 amRNSHalf Yearly Report
4th Jul 20237:00 amRNSAppointment of COO
9th May 20237:00 amRNSInterim Trading Update
4th May 20233:30 pmRNSResult of AGM
28th Mar 20237:00 amRNSAnnual Report and Notice of AGM
13th Mar 20237:00 amRNSFinal Results
1st Nov 20227:00 amRNSQ3 Trading Update
5th Sep 202211:21 amRNSGreenhammer Commercial Contract
9th Aug 202210:15 amRNSHolding(s) in Company
8th Aug 20227:00 amRNSHalf Yearly Report
9th May 20227:00 amRNSInterim Trading Update
5th May 20223:00 pmRNSResult of AGM
5th Apr 20227:00 amRNSAnnual Report and Notice of AGM
15th Mar 20227:00 amRNSHolding(s) in Company
14th Mar 20227:00 amRNSDirector Appointment
14th Mar 20227:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.